Authors
Loading...
Cost-effectiveness analysis reveals local antibacterial brands are superior against E. coli and Staph. aureus.
Al-Ghani et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: